Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

European Association of Urology Research Foundation clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Spain, Italy, Belgium, Germany, Norway, Ireland, Poland, France, Sweden, Portugal, Netherlands and Czechia registers with European Association of Urology Research Foundation as lead sponsor. Synced 17 Nov 2026
4Current trials
0Recruiting now
0Drugs in these trials
12Trial registers
At a glance

European Association of Urology Research Foundation is the lead sponsor of 4 current clinical trials in our Spain, Italy, Belgium, Germany, Norway, Ireland, Poland, France, Sweden, Portugal, Netherlands and Czechia registers. None of its ClinicalTrials.gov trials is recruiting at the moment. All registered phases are Observational. The most-studied condition is Prostate Cancer.

ClinicalTrials.gov trials by status

  • Active, closed375%
  • By invitation125%

Trials by phase

  • Observational4100%
01

Clinical trials sponsored by European Association of Urology Research Foundation

4 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Prostate Cancer Awareness and Initiative for Screening in the European Union
NCT06424275 · Prostate Cancer
Observational By invitation 2024-06 Ireland, Spain, Poland
Optilume Registry for Treatment of Stricture of the Anterior Urethra
NCT05479422 · ClinicalTrials.gov ↗ · Anterior Urethral Stricture, Male
Observational Active, closed 2022-10 Spain, Italy, Belgium, Norway
Registry for Patients Undergoing Penile Prosthesis Implantation for Male Erectile Dysfunction
NCT03849586 · ClinicalTrials.gov ↗ · Erectile Dysfunction
Observational Active, closed 2021-11 Germany, France, Spain, Italy, Belgium, Sweden, Portugal
Prospective Registry for Patients Undergoing Surgery for Male Stress Urinary Incontinence
NCT02757274 · ClinicalTrials.gov ↗ · Urinary Incontinence, Stress
Observational Active, closed 2017-02 Germany, Spain, Italy, Netherlands, Belgium, Czechia, Norway

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in European Association of Urology Research Foundation trials

4 conditions
Prostate Cancer1Erectile Dysfunction1Urinary Incontinence, Stress1Anterior Urethral Stricture, Male1
05

Questions about European Association of Urology Research Foundation trials

How many clinical trials does European Association of Urology Research Foundation sponsor?

European Association of Urology Research Foundation is the lead sponsor of 4 current trials on ClinicalTrials.gov in our Spain, Italy, Belgium, Germany, Norway, Ireland, Poland, France, Sweden, Portugal, Netherlands and Czechia registers, as of the registry sync on 17 November 2026. Completed and withdrawn studies are not counted.

Are European Association of Urology Research Foundation trials recruiting?

Not at the moment. None of its 4 ClinicalTrials.gov trials is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.

Does European Association of Urology Research Foundation have clinical trials in Ireland?

Yes. 1 trial in our Ireland register (ClinicalTrials.gov). Some may be the same study registered in both. See the Irish clinical trials register for sites and contacts.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 17 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.